9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
Merck Sharp & Dohme LLC
OHSU Knight Cancer Institute
OncoSec Medical Incorporated
NYU Langone Health
Celgene
Celgene
Incyte Corporation
Celgene Corporation
Veeda Oncology
Celgene Corporation